Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the U.S. Food and Drug Administration (FDA) has removed the ...

A clinical trial has found that Novavax’ COVID-19 vaccine is 86% protective against the UK variant of SARS-CoV-2, only slightly lower than the 96% efficacy seen with the original strain of the ...

Inovio Pharmaceuticals Inc.-3.56% $138.65M ...

A trial participant developed amytrophic lateral sclerosis (ALS), an event deemed unrelated to vaccination. Novavax’s shares jumped in pre-market trading on the news but settled once markets opened.

If you’re looking to pick up more Monopoly Go stickers to complete your in-game sticker albums, we’re here to help. Completing albums is one of the best ways to pick up more in-game resources like ...

Eliminating fake vaccine news with pharmacist, nurse, and physician review.